MedPath

IDELVION

IDELVION

Approved
DIN Number

02489627

Drug Class

Human

Market Date

N/A

Company
HC

csl behring canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02489627
AIG Number0157770005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BD04 COAGULATION FACTOR IX
Product Specifications
Dosage FormKit ,  Powder For Solution
Route of AdministrationIntravenous
AHFS Classification20:28.16
Health Canada Classification

ACTIVE INGREDIENTS (1)

COAGULATION FACTOR IX (RECOMBINANT), ALBUMIN FUSION PROTEIN (RIX-FP)Active
Strength: 3500 UNIT / VIAL
Monograph: COAGULATION FACTOR IX (RECOMBINANT), ALBUMIN FUSION PROTEIN (RIX-FP)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.